First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Holdings of the Fund as of 9/15/2025

Total Number of Holdings (excluding cash): 48

Security Name Identifier CUSIP Classification Shares / Quantity Market Value Weighting Descending sort
Johnson & Johnson JNJ 478160104 Pharmaceuticals 6,956 $1,233,994.40 8.05%
AbbVie Inc. ABBV 00287Y109 Pharmaceuticals 5,494 $1,195,549.34 7.80%
Pfizer Inc. PFE 717081103 Pharmaceuticals 43,450 $1,041,496.50 6.79%
Merck & Co., Inc. MRK 58933Y105 Pharmaceuticals 12,449 $1,008,617.98 6.58%
Bristol-Myers Squibb Company BMY 110122108 Pharmaceuticals 19,265 $892,932.75 5.82%
United Therapeutics Corporation UTHR 91307C102 Pharmaceuticals 1,795 $723,582.45 4.72%
Viatris Inc. VTRS 92556V106 Pharmaceuticals 62,238 $597,484.80 3.90%
Biogen Inc. BIIB 09062X103 Biotechnology 4,089 $586,035.48 3.82%
Gilead Sciences, Inc. GILD 375558103 Pharmaceuticals 5,025 $565,513.50 3.69%
Amgen Inc. AMGN 031162100 Pharmaceuticals 1,859 $510,109.60 3.33%
Zoetis Inc. ZTS 98978V103 Pharmaceuticals 3,424 $500,760.00 3.27%
Jazz Pharmaceuticals Plc JAZZ G50871105 Pharmaceuticals 3,989 $499,502.58 3.26%
Regeneron Pharmaceuticals, Inc. REGN 75886F107 Biotechnology 819 $468,951.21 3.06%
Eli Lilly and Company LLY 532457108 Pharmaceuticals 622 $465,374.18 3.04%
Elanco Animal Health Incorporated ELAN 28414H103 Pharmaceuticals 23,419 $436,530.16 2.85%
Medpace Holdings, Inc. MEDP 58506Q109 Biotechnology 870 $431,876.70 2.82%
Exelixis, Inc. EXEL 30161Q104 Biotechnology 7,821 $305,097.21 1.99%
Charles River Laboratories International, Inc. CRL 159864107 Biotechnology 1,987 $302,500.88 1.97%
Illumina, Inc. ILMN 452327109 Biotechnology 2,996 $302,356.32 1.97%
Organon & Co. OGN 68622V106 Pharmaceuticals 27,775 $288,860.00 1.88%
Halozyme Therapeutics, Inc. HALO 40637H109 Biotechnology 3,636 $277,535.88 1.81%
Neurocrine Biosciences, Inc. NBIX 64125C109 Biotechnology 1,811 $254,336.84 1.66%
BioMarin Pharmaceutical Inc. BMRN 09061G101 Pharmaceuticals 2,815 $149,589.10 0.98%
Amneal Pharmaceuticals, Inc. AMRX 03168L105 Pharmaceuticals 15,230 $149,101.70 0.97%
Alnylam Pharmaceuticals, Inc. ALNY 02043Q107 Biotechnology 320 $147,564.80 0.96%
Insmed Incorporated INSM 457669307 Biotechnology 968 $138,559.52 0.90%
Alkermes Plc ALKS G01767105 Pharmaceuticals 5,110 $135,517.20 0.88%
Perrigo Company Plc PRGO G97822103 Pharmaceuticals 5,203 $113,165.25 0.74%
Guardant Health, Inc. GH 40131M109 Biotechnology 1,855 $101,635.45 0.66%
ACADIA Pharmaceuticals Inc. ACAD 004225108 Biotechnology 4,028 $99,370.76 0.65%
Madrigal Pharmaceuticals, Inc. MDGL 558868105 Biotechnology 231 $98,313.60 0.64%
Cardinal Health, Inc. CAH 14149Y108 Pharmaceuticals 610 $91,664.70 0.60%
Catalyst Pharmaceuticals, Inc. CPRX 14888U101 Biotechnology 4,694 $92,753.44 0.60%
Corcept Therapeutics Inc. CORT 218352102 Pharmaceuticals 1,303 $90,597.59 0.59%
Exact Sciences Corporation EXAS 30063P105 Biotechnology 1,665 $88,960.95 0.58%
Incyte Corporation INCY 45337C102 Biotechnology 1,074 $89,292.36 0.58%
Prestige Consumer Healthcare Inc. PBH 74112D101 Pharmaceuticals 1,402 $88,283.94 0.58%
PTC Therapeutics, Inc. PTCT 69366J200 Biotechnology 1,429 $84,282.42 0.55%
TG Therapeutics, Inc. TGTX 88322Q108 Biotechnology 2,624 $83,312.00 0.54%
ADMA Biologics, Inc. ADMA 000899104 Biotechnology 4,817 $73,700.10 0.48%
Axsome Therapeutics, Inc. AXSM 05464T104 Biotechnology 619 $72,283.74 0.47%
Veracyte, Inc. VCYT 92337F107 Biotechnology 2,271 $72,376.77 0.47%
Akero Therapeutics, Inc. AKRO 00973Y108 Biotechnology 1,607 $68,859.95 0.45%
Krystal Biotech, Inc. KRYS 501147102 Biotechnology 440 $68,512.40 0.45%
Scholar Rock Holding Corporation SRRK 80706P103 Biotechnology 2,034 $68,484.78 0.45%
Vertex Pharmaceuticals Incorporated VRTX 92532F100 Pharmaceuticals 165 $64,879.65 0.42%
US Dollar $USD Other 51,420 $51,419.80 0.34%
Vericel Corporation VCEL 92346J108 Biotechnology 1,539 $48,355.38 0.32%
Sarepta Therapeutics, Inc. SRPT 803607100 Biotechnology 740 $12,927.80 0.08%
Holdings are subject to change.

The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.